201 related articles for article (PubMed ID: 8128694)
1. Role of platelet adhesion and aggregation in antithrombotic therapy.
Ruggeri ZM
West J Med; 1993 Dec; 159(6):702-4. PubMed ID: 8128694
[No Abstract] [Full Text] [Related]
2. [Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
Panchenko EP
Ter Arkh; 1997; 69(9):66-71. PubMed ID: 9411833
[No Abstract] [Full Text] [Related]
3. [Antithrombotic agents, pharmacologic principles].
Markwardt F
Z Arztl Fortbild (Jena); 1986; 80(14):565-70. PubMed ID: 3765695
[No Abstract] [Full Text] [Related]
4. Vitamins and minerals that affect hemostasis and antithrombotic therapies.
Rebecca Couris R
Thromb Res; 2005; 117(1-2):25-31; discussion 39-42. PubMed ID: 16257439
[No Abstract] [Full Text] [Related]
5. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
[TBL] [Abstract][Full Text] [Related]
7. Platelet-suppressive therapy in cardiovascular disease.
Mehta J; Roy L
Cardiovasc Clin; 1984; 14(3):211-34. PubMed ID: 6722852
[No Abstract] [Full Text] [Related]
8. Prophylactic agents for thrombosis.
Castaldi PA
Drugs; 1975; 9(1):1-3. PubMed ID: 1126303
[No Abstract] [Full Text] [Related]
9. [Antiplatelet therapy in mitral stenosis].
Muroi S
J Cardiogr; 1983 Mar; 13(1):211. PubMed ID: 6644117
[No Abstract] [Full Text] [Related]
10. [Fundamentals of antithrombotic therapy].
Markwardt F
Z Gesamte Inn Med; 1979 Jan; 34(1):1-3. PubMed ID: 433359
[TBL] [Abstract][Full Text] [Related]
11. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.
Grüner S; Prostredna M; Aktas B; Moers A; Schulte V; Krieg T; Offermanns S; Eckes B; Nieswandt B
Circulation; 2004 Nov; 110(18):2946-51. PubMed ID: 15505105
[TBL] [Abstract][Full Text] [Related]
12. [Round table discussion on current antithrombotic therapy].
Angiologia; 1973; 25(5):215-54. PubMed ID: 4725326
[No Abstract] [Full Text] [Related]
13. [Effect of xanthine derivatives on thrombocyte aggregation and other hemostatic indices].
Lakin KM; Ovnatanova MS; Matiashova MA; Mashkovskiĭ MD
Biull Eksp Biol Med; 1980 Feb; 89(2):181-2. PubMed ID: 7370418
[TBL] [Abstract][Full Text] [Related]
14. Agents for antithrombotic therapy.
Conroy JD; Kahn SB
Am Fam Physician; 1986 Aug; 34(2):192-6. PubMed ID: 3751834
[No Abstract] [Full Text] [Related]
15. [Current place of anticoagulants, fibrinolytic and anti-aggregation agents in the prevention of thrombosis].
Bousser MG; Samama M
Therapeutique; 1973 Nov; 49(9):619-25. PubMed ID: 4792904
[No Abstract] [Full Text] [Related]
16. [Platelet antiaggregants].
Huisse MG
Soins; 1985 May; (454):38-40. PubMed ID: 3848127
[No Abstract] [Full Text] [Related]
17. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
18. [New agents and challenges in the antithrombotic management of arterial diseases].
Udvardy M; Rák K
Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
[TBL] [Abstract][Full Text] [Related]
19. [Hyperaggregability of platelet in acute stage of thrombosis (author's transl)].
Yamazaki H; Takahashi T; Mashimo N
Rinsho Ketsueki; 1973 Dec; 14(0):1365-71. PubMed ID: 4807611
[No Abstract] [Full Text] [Related]
20. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
